Clinical Trial Update: A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug

View source ↗

Summary

Completed pharmacokinetic study evaluating how liver impairment affects dasatinib processing in liver-impaired and healthy subjects. The trial aims to inform do…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• Sprycel (dasatinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Liver Diseases | Status: COMPLETED